* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Fulltext PDF
Eukaryotic transcription wikipedia , lookup
Cell-penetrating peptide wikipedia , lookup
RNA polymerase II holoenzyme wikipedia , lookup
Messenger RNA wikipedia , lookup
Genome evolution wikipedia , lookup
RNA silencing wikipedia , lookup
Bottromycin wikipedia , lookup
Transcriptional regulation wikipedia , lookup
Polyadenylation wikipedia , lookup
Silencer (genetics) wikipedia , lookup
List of types of proteins wikipedia , lookup
Protein structure prediction wikipedia , lookup
Point mutation wikipedia , lookup
Amino acid synthesis wikipedia , lookup
Deoxyribozyme wikipedia , lookup
Molecular evolution wikipedia , lookup
Gene expression wikipedia , lookup
Biochemistry wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Non-coding RNA wikipedia , lookup
Genetic code wikipedia , lookup
Nucleic acid analogue wikipedia , lookup
Expanded genetic code wikipedia , lookup
GENERAL ARTICLE Modified Bases in Mycobacterial Transfer RNA Vani Brahmachari Vani Brahmachari did her doctoral research at the Microbiology and Cell Biology Department, IISc, under the guidance of Prof. T Ramakrishnan. She is presently a professor at Dr. Ambedkar Centre for Biomedical Research, University of Delhi. Her research focus is in the area of epigenetic mechanisms and developmental biology. She is also engaged in mining the human genome to discover genes involved in epigenetic regulation and on functional analysis of M. tuberculosis genome. The presence of post-transcriptionally modified bases in nucleic acids is associated with various regulatory mechanisms. The transfer RNA is particularly rich in modified bases. The article discusses some of Prof. T Ramakrishnan’s contributions to the filed in the context of the times, which illustrate his foresight. There are more than 100 modifications reported for transfer RNA (tRNA) which entered the field of molecular biology when Francis Crick proposed the role for an adaptor molecule to decode the information contained in DNA into proteins. Nature has invested considerably in generating and maintaining modified bases including all the genes coding for catalytic functions to modify nucleotides after transcription. It was the belief that such a strategy indeed would have an important role in the biology of Mycobacterium that Prof. Ramakrishnan took up research on modified bases in RNA in the bacterium, anticipating that the modifying enzymes could be potential drug targets. I will try and summarise his work which led to the sequencing of the initiator tRNAfMet, and the elucidation of unique features of Mycobacterial tRNAs. Transfer RNA – The Adaptor Molecule Keywords Mycobacterium tuberculosis, tRNA, modified bases. 746 Transfer RNAs are ubiquitous and are considered ancient molecules that directly interface between the information contained in DNA and the amino acid sequence of a protein (Figure 1). They are small in size, typically between 73 to 93 bases, most often 76 nucleotides, approximately 25kd in molecular mass. They were discovered as soluble ribonucleic acid intermediates in protein synthesis by Paul Zamecnik in 1958. Alanine tRNA of yeast was the first to be sequenced by Holley and coworkers. Based on the sequence, they proposed the famous cloverleaf structure of tRNA by applying the criteria of maximum base RESONANCE August 2009 GENERAL ARTICLE (A) (B) Figure 1. Transfer RNA molecules interface information transfer between DNA and protein. (A) Charging of cognate amino acid to specific tRNA by aminoacyl-tRNA synthetase. Energy released by ATP hydrolysis is utilized, forming AMP and pyrophosphate (PPi). (B) The amino acid is carried at the 3’CCA end of tRNA, attached to the 3’OH of the ribose moiety and placed on the ribosome, through recognition of the codon on mRNA. P and A stand for entry sites (P site and A site) for aminoacyl-tRNA on ribosomes. Only the initiator tRNA directly enters the P site on ribosomes while all other aminoacyl-tRNA enter A site. RESONANCE August 2009 747 GENERAL ARTICLE Figure 2. Cloverleaf structure of initiator tRNA of Mycobacterium smegmatis. This also illustrates the general structural features of transfer RNA described in the text. The features unique to initiator tRNA of Mycobacterium are marked: the presence of 1-methyl adenine (m 1 A) and uracil in place of thymine found in almost all other tRNAs. pairing. The cloverleaf structure of tRNA elegantly fits an adapter molecule with attachment of specific amino acid on its 3’end and the anticodon presented as a single-stranded loop that can interact with the codon on mRNA. The L-shaped three-dimensional structure of tRNA was deciphered by high resolution X-ray crystallography by Alexander Rich and coworkers. The cloverleaf structure has four stems and three loops; the stems being designated either by the modified base they carry or their function (Figure 2). A highly conserved single-stranded sequence N73CCA-OH (N for any of the four nucleotides), is present at the end of the acceptor stem-loop and the terminal adenosine contains free 2’ and 3’ hydroxyl groups where an amino acid is attached. Two or three base pairs in the acceptor stem vary between tRNAs and are referred to as the 'discriminator’ nucleotide. The first base from the 5’end and the 72nd base remain unpaired in prokaryotes while they are always paired in eukaryotes. Then there is the TC stem-loop with psudouridine (, Figure 1B) and ribothymidine. The anticodon stem-loop contains the three-lettered anticodon as N35N36N37 that directs the interaction of tRNA with the codon on the mRNA. The D stem-loop contains dihydrouridine. The L-shaped threedimensional structure comes about by stacking acceptor stem-loop on TC stem-loop and D stem-loop on anticodon stem-loop. Transfer RNAs are coded in the bacterial genome often as operons with a common promoter and transcribed as a long transcript from which each tRNA is cleaved by RNAse activity. For example, tRNAArginine, tRNAHistidine, tRNALeucineand tRNAProline exist as an operon in E. coli. The role of tRNA in protein synthesis is very critical to maintain the accuracy of information transfer from the DNA to protein. The process of attachment of an amino acid to the right tRNA is catalysed by aminoacyl tRNA synthetases (aa-tRNA synthetase) in two steps. There are 20 different enzymes to specifically charge the amino acid to the right tRNA with matching 748 RESONANCE August 2009 GENERAL ARTICLE anticodon. In the first step the amino acid is activated by ATP to form tRNA synthetase (amino acid-AMP) which in the second step is loaded on tRNA to form aminoacyl tRNA (aa-tRNA). One may wonder as to how this specificity is maintained. Nobel Laureate Chrisitan de Devu commented that the second genetic code is written into the structure of aminoacyl-tRNA synthetase [1]. He also adds “….(this) code is probably nondegenerate and could be older and more deterministic than the genetic code”. While the codon–anticodon interaction is a single language of nucleic acids, the specificity of charging the right amino acid on the cognate tRNA is 'bilingual', involving a protein and a nucleic acid. The major role played by aa-tRNA sythetase in maintaining the fidelity in charging of tRNA with the right amino acid was subsequently deciphered. It is accepted that the nature of the base at 73 position and one or two base pairs among the first four in acceptor stem are important for fidelity. It was also shown that anticodon has no role in achieving this specificity, as specific amino acylation can take place even when the anticodon stem-loop is removed. Modified Bases in Transfer RNA The presence of modified bases in tRNA was suspected when amino acid accepting activity of E. coli tRNA was found to be resistant to ribonuclease, an enzyme that can hydrolyse RNA. This work was carried out by Susumu Nishimura who was earlier at the National Cancer Centre Research Institute, Tokyo and presently at the University of Tsukuba, Japan. Subsequently, in collaboration with Har Gobind Khorana’s group, by sequencing E. coli tRNATyrosine he found that tRNAs have unusual bases. The presence of multiple codons for one amino acid demands a calculated mispairing of bases referred to as ‘wobble base pairing’, which is facilitated by modified nucleotides at the first position of the anticodon. There are more than 100 modifications reported for tRNA from different sources (Figure 3). Nishimura and his group carried out structural analysis of several modified nucleotides. After a sabbatical at Japan in 1978, Prof. Ramakrishnan (TR as he was fondly addressed by his students) established collaboration with Nishimura and analysed modified bases in tRNA and ribosomal RNA in Mycobacteria. TR had a project which was directed at analyzing whether Mycobacterium tuberculosis as well as other non-pathogenic species of Mycobacteria have any base modifications. The goal was to explore if the uniqueness of base modification, if any, in Mycobacteria, which could be exploited for chemotherapy of tuberculosis. The work began with an observation that enzyme fractions from M. smegmatis, could methylate total tRNA from E. coli. The results were reported in a paper presented by M S Shaila and TR at a symposium organized by the Department of Atomic Energy at Mumbai. Though the substrate tRNA in these reactions was completely modified within E. coli cells, enzymes from M. smegmatis could add methyl groups RESONANCE August 2009 749 GENERAL ARTICLE Figure 3. Structure of modified bases found in tRNA. Representative modifications of each of the four bases are shown. Lysidine and Q base are complex modifications of cytidine and purine respectively. Note that both base and sugar modifications are known to occur in tRNA. The structures are taken from http://library.med.utah.edu/RNAmods available in the public domain. to it. This suggested that the modified base composition of tRNA in M. smegmatis is different from that of E. coli tRNA. Similarly in a reciprocal reaction, the enzymes from E. coli also found the tRNA from M.smegmatis lacking some modifications. This led to the discovery that M. smegmatis tRNA contains 1-methyl adenine (m1A) (which is absent in E. coli tRNA) but lacks ribothymidine in the TC loop. A detailed analysis of base composition of total tRNA from M. smegmatis was taken up [2]. E. coli tRNAs are enriched in modified nucleotides, while they are considerably less in Mycobacterial tRNAs. 750 RESONANCE August 2009 GENERAL ARTICLE It is well known that thymine is almost exclusively found in DNA; RNA molecules contain uracil in its place. However as seen in the cloverleaf structure of tRNA (Figure 2), there is thymine residue in almost all tRNAs in the TC loop. The difference between uracil and thymine is the presence of –CH3 group on the 5th carbon in the pyrimidine ring in the latter. What is interesting is that this residue is not incorporated into tRNA during transcription of tRNA gene but is added later as a post-transcriptional modification. It was not known what is present in place of thymidine in TC loop and which adenine was converted to 1-methyl adenine in M. smegmatis tRNAs. 1-methyl adenine is generally found in tRNA from eukaryotes but not in prokaryotes. These issues were resolved by two approaches by TR’s group in collaboration with Nishimura’s group. In one case they completely sequenced the initiator tRNA of M. smegmatis. In the other, they developed a novel method to map the modified bases within the tRNA structure starting with total tRNA. Sequencing of Initiator tRNA The complete sequence of transfer RNAs from many species is now known. The initiator tRNA is charged with formylated methionine, which is the initiation codon for protein synthesis in prokaryotes in almost all genes and this tRNA enters the P site on the ribosomes (Figure 1). There are characteristic differences in initiator tRNA sequence between species. Therefore to examine if the sequence of initiator tRNA of Mycobacteria is similar to that of eukaryotes or eubacteria (true bacteria like E. coli) complete sequencing of tRNAfMet from M. smegamtis was taken up. Around this time Nishimura’s group had developed a novel method for sequencing tRNAs, that uniquely identified the modified nucleotides also while sequencing. The major method used for identification of modified bases at that time was thin layer chromatography (TLC) which took advantage of differential partition of nucleotides between a mobile phase and a stationary phase, while sequencing was based on identifying the 5’end nucleotide of fragments of tRNA fractionating based on size by electrophoresis. Kuchino in Nishimura’s group ingeniously combined the two to read the sequence as well as the modification, if any, on the nucleotide. A limited cleavage of pure initiator tRNA by hot formamide generates a single random cut on each tRNA molecule. These have a hydroxyl group at the 5’end and therefore can accept radioactive phosphate group. When this pool of fragments is subjected to electrophoresis they separate based on size and each one differs from the immediate smaller fragment by one nucleotide. Each band is cut out from the gel and digested with RNAse P1 that cleaves them to give 5’phosphate containing nucleosides. Then the mixture of nucleotide monophosphates is separated by TLC. Each 5’end nucleotide can be identified as labeled radioactive monophosphate, on exposure of the TLC plates to X-ray films. The advantage was RESONANCE August 2009 751 GENERAL ARTICLE that based on the position on the TLC plate one could not only identify all the normal nucleotides but also the modified nucleotides unambiguously. In parallel the tRNA was sequenced by a second method. Reading the thesis where this is described, I realized that the 32P ATP that is required for the exchange reaction was also synthesized in the lab while it is only a phone call/e-mail away now! The sequence of initiator tRNAfMet of M. smegmatis obtained by this method is shown in Figure 2. The features of having m1A as the 5th base and uridine in place of ribothymidine, and also G.C, C.G, G.C as the base pairs at the 5’ end showed that initiator tRNA of M. smegmatis shares its sequence features with Streptomyces [8]. It was interesting to know that m1A is present in tRNA from other species of Mycobacteria including M. tuberculosis. TR’s group also purified the enzyme that mediates this methylation [9]. With a desire to design new active principles for potential therapeutic use against tuberculosis, an organic chemist Ramamurthy joined TR’s group to synthesise analogues of adenine, coded as SIBA. When tested it was found to have inhibitory activity on the formation of m1A. His group tried to analyse the functional significance of this modification by measuring the efficiency of cross aminoacylation of E. coli tRNA with and without m1A. Unfortunately some of these results remained unpublished. After a gap of about two decades, in the Department of Microbiology and Cell Biology at IISc where TR did all his work and also led the department as the Chairman for many years, Umesh Varshney took up work on initiator tRNA and m1A tRNA methylase from M. tuberculosis. He observed that there is a single copy of initiator tRNA gene in both M. smegmatis and M. tuberculosis. In M. tuberculosis the CCA end is encoded in the gene while in M.smegmatis it is added after transcription. Varshney’s group found that m1A tRNA methylase differs from that of yeast not only in its subunit composition but also in biochemical properties. In yeast, knock out of m1A tRNA methylase is lethal. Varshney et.al suggest that m1A methylase could be a potential drug target. The crystal structure of the enzyme was also solved by Varshney and coworkers. Do Modified Bases Have Functional Significance? Modified bases within or adjacent to the anticodon are important for filling in for codon degeneracy. For example valine has three codons GUU, GUA and GUG in E. coli. Valyl tRNA that contains Uridine-5-oxyacetic acid in the first position of the anticodon can recognize all three codons while this property is lost when the modification is absent. Base modification containing sulphur groups are known to confer thermal stability to tRNA from Thermus thermophilus bacteria. More recently, it is found that tRNAs from tumour cells are less modified than their counterparts from normal cells. Point mutation in one of the tRNALeu coding 752 RESONANCE August 2009 GENERAL ARTICLE genes in mitochondria causes diseases called MELAs (mitochondrial myopathy, encephalopathy) and MERRF (a form of myoclonus epilepsy). The molecular basis of pathology in these diseases is attributed to the absence of modified base in tRNALeu due to single nucleotide variation in the gene. Thus tRNA modifications appear to fine-tune protein production in cells. In spite of this, targeting enzymes that modify bases in several tRNAs remains an unexplored area for drug discovery specially for infectious diseases like tuberculosis. It is very gratifying personally for me to have been associated with the work that TR carried out on modified nucleotides in tRNA, though as a tail-ender in the long list of his illustrious students. Suggested Reading [1] C de Duve, The second genetic code, Nature, Vol.333, p.117, 1988. [2] B R Vani, T Ramakrishnan, Y Taya, S Noguchi, Z Yamazumi and S Nishimura, Occurrence of 1methyladenosine and absence of ribothymidine in transfer ribonucleic acid of Mycobacterium smegmatis, J. Bacteriology, Vol.137, No.3, pp.1084–1087, 1979. [3] [4] K P Gopinathan, T Ramakrishnan (1922-2008) Personal News, Current Science, Vol.94, No.7. pp.935–936, 2008. V Brahmachari, T Ramakrishnan, Modified bases in transfer RNA, J. Biosciences, Vol.6, No.5, pp.757–770, 1984. [5] P Schimmel, L R de Pouplana, Transfer RNA; From minihelix to genetic code, Cell, Vol.81, pp.983–986, 1995. [6] S Nishimura and K Watanabe, Discovery of modified nucleosides from the early days to the present: A personal perspective, J. Biosciences, Vol.31, No.4. pp.465–475, 2006. [7] R Giege, Towards a more complete view of tRNA biology, Nature Structural and Molecular Biology, Vol. 15, No.10, pp.1007–1014, 2008. [8] B R Vani, T Ramakrishnan, Y Kuchino and S Nishimura, Nucleotide sequence of initiator tRNA from Mycobacterium smegmatis, Nucleic Acids Research, Vol.12, No.9, pp.3933–3936, 1984. [9] V Brahmachari and T Ramakrishnan, Studies on 1-methyl adenine transfer RNA methyltransferase of Myco bacterium semgmatis, Arch. Microbiology, Vol.140, pp.91–95, 1984. Address for Correspondence Vani Brahmachari, Dr B R Ambedkar Center for Biomedical Research, University of Delhi, Delhi 110 007, India. Email: [email protected] RESONANCE August 2009 753